Arkema

AKE

FR0010313833

Commodity Chemicals

Market Closed - Euronext Paris Other stock markets 11:35:28 2024-04-19 am EDT			5-day change	1st Jan Change
95.6 ^EUR	-1.80%		-1.90%	-7.18%

Apr. 18	Arkema to Acquire Majority Stake in Austria's Proionic	MT
Apr. 18	Arkema: agreement to acquire Proionic	CF

Arkema: Disclosure of Trading in Own Shares from 22 February to 26 February 2021

March 02, 2021 at 08:55 am EST

Regulatory News:

In accordance with applicable regulations, Arkema (Paris:AKE) announces having carried out the following share buyback transactions in accordance with Article 5 §2 of Regulation (EU) No 596/2014 from 22 February to 26 February 2021

Name of the issuer	Issuer identifier code	Day of the transaction	Financial instrument identifier code	Total daily volume (number of shares)	Weighted average price of daily acquisition	Market identifier code
ARKEMA	9695000EHMS84KKP2785	2/22/2021	FR0010313833	7000	89,9249	XPAR
ARKEMA	9695000EHMS84KKP2785	2/23/2021	FR0010313833	7000	89,0831	XPAR
ARKEMA	9695000EHMS84KKP2785	2/24/2021	FR0010313833	7000	90,0331	XPAR
ARKEMA	9695000EHMS84KKP2785	2/25/2021	FR0010313833	7000	92,4389	XPAR

			TOTAL	28 000	90,3700

Detailed information can be found on the Group Arkema website:
https://www.arkema.com/en/investor-relations/arkema-share/share-buybacks/2020/

View source version on businesswire.com: https://www.businesswire.com/news/home/20210302005732/en/

Latest news about Arkema

Arkema to Acquire Majority Stake in Austria's Proionic	Apr. 18	MT
Arkema: agreement to acquire Proionic	Apr. 18	CF
Arkema S.A. signed an agreement to acquire 78% stake in proionic.	Apr. 16	CI
Arkema sites visited by investigators, chemicals group says	Apr. 09	RE
Arkema: BlackRock holds less than 5% of the capital	Apr. 05	CF
Arkema: BlackRock holds less than 5% of the capital	Apr. 02	CF
Arkema: BlackRock crosses the 5% threshold	Mar. 28	CF
Arkema: BlackRock below 5% of share capital	Mar. 26	CF
ARKEMA : Oddo BHF confirms its recommendation on the stock	Mar. 21	CF
Arkema: BlackRock exceeds 5% of share capital	Mar. 20	CF
Arkema: BlackRock exceeds 5% of share capital	Mar. 15	CF
Arkema: placement of hybrid bonds	Mar. 15	CF
French Chemicals Group Arkema Launches EUR400 Million Undated Hybrid Bond	Mar. 15	MT
Moody's Maintains Arkema's Rating, Outlook	Mar. 12	MT
Arkema: BlackRock exceeds 5% of share capital	Mar. 08	CF
Berenberg Downgrades Arkema to Hold from Buy, Cuts PT	Mar. 06	MT
ARKEMA : Berenberg lowers its recommendation	Mar. 06	CF
Arkema: struggling, an analyst lowers his recommendation	Mar. 06	CF
ARKEMA : Higher depreciation obscures a somewhat better operating performance	Mar. 04
ARKEMA : Some profit taking after a moderate outlook	Mar. 03
Eight arrested as climate activists break into chemicals plant in France	Mar. 02	RE
ARKEMA : Stifel lowers its target price	Mar. 01	CF
CAC40: closes at half-mast despite morning record	Feb. 29	CF
CAC40: disappointing end to session, W-Street flirts with records	Feb. 29	CF
CAC40: zero reaction to US PCE, but February ends on a high note	Feb. 29	CF

Chart Arkema

Duration

Period

More charts

Company Profile

Arkema is one of the world's leaders in the development, manufacturing and marketing of chemical products. Net sales break down by family of products as follows: - advanced materials (37.4%): high performance polymers, specialty surfactants, molecular sieves, organic peroxides, oxygenates, etc.; - adhesives (28.5%): sealants, adhesives for floors and tiles, waterproofing products, etc.; - coating solutions (25.3%): resins, emulsions for adhesives, surface coating products, absorbents, etc.; - intermediate products (8.4%): thermoplastic polymers (PMMA), acrylic products, fluorinated gases, etc.; - other (0.4%). At the end of 2023, the group had 148 production sites worldwide. Net sales are distributed geographically as follows: France (7.8%), Europe (26.6%), United States-Canada-Mexico (36.5%), China (11%), Asia (12.6%) and others (5.5% ).

Sector

Commodity Chemicals

Calendar

2024-05-07 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

ARKEMA : Higher depreciation obscures a somewhat better operating performance

March 04, 2024 at 05:30 am EST

More Strategies

Ratings for Arkema

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

95.6 EUR

Average target price

110.4 EUR

Spread / Average Target

+15.52%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Commodity Chemicals

	1st Jan change	Capi.
ARKEMA	-7.18%	7.63B
AIR LIQUIDE	+6.61%	105B
SAUDI BASIC INDUSTRIES CORPORATION	-3.11%	64.7B
WANHUA CHEMICAL GROUP CO., LTD.	+12.67%	37.53B
PT CHANDRA ASRI PACIFIC TBK	+30.48%	36.55B
LYONDELLBASELL INDUSTRIES N.V.	+5.95%	32.78B
WESTLAKE CORPORATION	+7.72%	19.37B
NINGXIA BAOFENG ENERGY GROUP CO., LTD.	+15.03%	17.16B
HENGLI PETROCHEMICAL CO.,LTD.	+22.17%	15.64B
RONGSHENG PETROCHEMICAL CO., LTD.	+9.37%	15.27B

Other Commodity Chemicals

Arkema

Equities

AKE

FR0010313833

Commodity Chemicals

Arkema: Disclosure of Trading in Own Shares from 22 February to 26 February 2021

EPS Revisions